---
title: "Chipscreen Biosciences' brain-penetrant CS231295 tablet gets FDA IND approval, advancing global clinical dev."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/250967186.md"
description: "Shenzhen-based company Chipscreen Biosciences Co., Ltd. has shared that its wholly owned subsidiary, Chipscreen Biosciences (USA) Ltd., has recently obtained Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA). This milestone was announced on July 31, 2025. The approval signifies a significant step forward for the company in advancing its pharmaceutical research and development efforts in the United States."
datetime: "2025-07-31T09:59:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/250967186.md)
  - [en](https://longbridge.com/en/news/250967186.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/250967186.md)
---

# Chipscreen Biosciences' brain-penetrant CS231295 tablet gets FDA IND approval, advancing global clinical dev.

Shenzhen-based company Chipscreen Biosciences Co., Ltd. has shared that its wholly owned subsidiary, Chipscreen Biosciences (USA) Ltd., has recently obtained Investigational New Drug (IND) approval from the U.S. Food and Drug Administration (FDA). This milestone was announced on July 31, 2025. The approval signifies a significant step forward for the company in advancing its pharmaceutical research and development efforts in the United States.

### Related Stocks

- [688321.CN](https://longbridge.com/en/quote/688321.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [14:47 ET6th Annual Midwest Design Awards Entry Period Now Open](https://longbridge.com/en/news/286808240.md)
- [Grown Up Group Sets June 2026 AGM to Approve Results and Share Mandate](https://longbridge.com/en/news/286990715.md)
- [New York Governor Signs Bills To Preserve Mandatory Vaccines](https://longbridge.com/en/news/286947583.md)
- [09:35 ETOpen Medicine Launches Ahead of ASCO, Introducing "Living Algorithms" for Real-Time Oncology Decision-Making](https://longbridge.com/en/news/286923155.md)